Ectopic insulin secreting neuroendocrine tumor of kidney with recurrent hypoglycemia: A diagnostic dilemma

BMC Endocrine Disorders

Volumn 14, Issue , 2014, Pages

  Ramkumar, S ^a   Dhingra, Atul ^a   Jyotsna, V P ^a   Ganie, Mohd A ^a   Das, Chandan J ^a   Seth, Amlesh ^a   Sharma, Mehar C ^a   Bal, Chandra S ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

68Ga Dotanoc scan; 99mTc HYNICTOC scan; Carcinoid tumor; Hyperinsulinemic hypoglycemia; Insulinoma; Neuroendocrine tumour; Renal tumour

Indexed keywords

C PEPTIDE; CHROMOGRANIN A; CYTOKERATIN; DOTANOC GA 68; GLUCOSE; GROWTH HORMONE; HEMOGLOBIN A1C; HYDROCORTISONE; HYNICTOC TC 99M; INSULIN; NEURON SPECIFIC ENOLASE; PANCYTOKERATIN; RADIOPHARMACEUTICAL AGENT; SOMATOMEDIN C; SYNAPTOPHYSIN; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG; GALLIUM 68; SOMATOSTATIN DERIVATIVE; TECHNETIUM 99M; 68GA-DOTANOC; ORGANOMETALLIC COMPOUND;

ADULT; ARTICLE; BEHAVIOR CHANGE; CANCER GRADING; CANCER STAGING; CASE REPORT; CELL ULTRASTRUCTURE; CHROMATIN; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; CYTOPLASM; DISEASE DURATION; DIZZINESS; ENDOCRINOLOGIST; EOSINOPHIL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GRANULAR CELL; GROWTH HORMONE BLOOD LEVEL; HEADACHE; HEART PALPITATION; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN RELEASE; KIDNEY CANCER; KIDNEY ECTOPIC INSULIN SECRETING NEUROENDOCRINE TUMOR; KIDNEY SCINTISCANNING; LABELING INDEX; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEMORY DISORDER; MICROSCOPY; MITOSIS RATE; NEPHRECTOMY; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR SHAPE; NUCLEOLUS; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; RECURRENT HYPOGLYCEMIA; SEIZURE; STROMA; SWEATING; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; CANCER SURGERY; CONVERSION DISORDER; ECTOPIC INSULIN SECRETION; HYPERINSULINEMIA; HYPOGLYCEMIC SEIZURE; INSULINOMA; KIDNEY TUMOR; PANIC; COMPLICATION; DIAGNOSTIC USE; HYPERINSULINISM; KIDNEY NEOPLASMS; MIDDLE AGED; NEUROENDOCRINE TUMORS; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; SECRETION (PROCESS);

FEMALE; HUMANS; HYPERINSULINISM; HYPOGLYCEMIA; INSULIN; INSULINOMA; KIDNEY NEOPLASMS; MIDDLE AGED; NEPHRECTOMY; NEUROENDOCRINE TUMORS; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS;

EID: 84902182667     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-14-36     Document Type: Article

References (18)

1. Immerman SC, Sener SF, Khandekar JD. Causes and evaluation of tumor-induced hypoglycemia. Arch Surg 1982, 117:905-908. 10.1001/archsurg.1982.01380310025006, 7092541.
2. Daughaday WH, Trivedi B. Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab 1992, 75:110-115.
3. Fakuda I, Hizuka N, Ishikawa Y, Yasumoto K, Murakami Y, Sata A, Morita J, Kurimoto M, Okubo Y, Takano K. Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia. Growth Horm IGF Res 2006, 16:211-216. 10.1016/j.ghir.2006.05.003, 16860583.
4. Filipi CJ, Higgins GA. Diagnosis and management of insulinoma. Am J Surg 1973, 125:231-239. 10.1016/0002-9610(73)90033-0, 4347229.
5. Morgello S, Schwartz E, Horwith M, King ME, Gorden P, Alonso DR. Ectopic insulin production by a primary ovarian carcinoid. Cancer 1988, 61:800-805. 10.1002/1097-0142(19880215)61:4<800::AID-CNCR2820610426>3.0.CO;2-3, 3276388.
6. Seckl MJ, Mulholland PJ, Bishop AE, Teale JD, Hales CN, Glaser M, Watkins S, Seckl JR. Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix. N Engl J Med 1999, 341:733-736. 10.1056/NEJM199909023411004, 10471459.
7. Shames JM, Dhurandhar NR, Blackard WG. Insulin-secreting bronchial carcinoid tumor with widespread metastases. Am J Med 1968, 44:632-637. 10.1016/0002-9343(68)90065-X, 4296076.
8. Fujino K, Yamamoto S, Matsumoto M, Su-nada M, Ota T. Paraganglioma associated with hypoglycemia. Intern Med 1992, 31:1239-1241. 10.2169/internalmedicine.31.1239, 1286235.
9. Uysal M, Temiz S, Gul N, Yarman S, Tanakol R, Kapran Y. Hypoglycemia due to ectopic release of insulin from a Paraganglioma. Horm Res 2007, 67:292-295. 10.1159/000099291, 17284922.
10. Frankton S, Baithun S, Husain E, Davis K, Grossman AB. Pheochromocytoma crisis presenting with profound hypoglycemia and subsequent hypertension. Hormones 2009, 8:65-70. 10.14310/horm.2002.1224, 19269923.
11. McCaffrey JA, Reuter VV, Herr HW, Macapinlac HA, Russo P, Motzer RJ. Carcinoid tumor of the kidney the use of somatostatin receptor scintigraphy in diagnosis and management. Urol Oncol 2005, 5:108-111.
12. Sundin A, Garske U, Orlefors H. Nuclear imaging of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 2007, 21(1):69-85. 10.1016/j.beem.2006.12.003, 17382266.
13. Armah HB, Parwani AV. Primary carcinoid tumor arising within mature teratoma of the kidney. Report of a rare entity and review of the literature. Diagn Pathol 2007, 2:15. 10.1186/1746-1596-2-15, 1884130, 17509135.
14. Jain D, Sharma MC, Singh K, Gupta NP. Primary carcinoid tumor of the kidney: case report and brief review of the literature. Indian J Pathol Microbiol 2010, 53(4):772. 10.4103/0377-4929.72087, 21045413.
15. Singh PP, Malhotra AS, Kashyap V. Carcinoid tumor of the kidney: an unusual renal tumor. Indian J Urol 2009, 25:537-538. 10.4103/0970-1591.57921, 2808663, 19955684.
16. Korkmaz T, Seber S, Yavuzer D, Gumus M, Turhal NS. Primary renal carcinoid: treatment and prognosis. Crit Rev Oncol Hematol 2013, 87:256-264. 10.1016/j.critrevonc.2013.02.003, 23478151.
17. Reubi JC, Kvols LK, Waser B, Nagorney DM, Heitz PU, Charboneau JW, Reading CC, Moertel C. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell tumors. Cancer Res 1990, 50:5969-5973.
18. McCaffrey JA, Reuter VV, Herr HW, Macapinlac HA, Russo P, Motzer RJ. Carcinoid tumor of the kidney the use of somatostatin receptor scintigraphy in diagnosis and management. Urol Oncol 2005, 5:108-111.